Dihydroxyacetone
|
Basic information |
| Metabolite name | Dihydroxyacetone |
 | HMDB0001882 |
 |
C00184 |
 |
670 |
| Synonyms | Glycerone |
| No. of studies | 6 |
|
Basic information |
| Metabolite name | Dihydroxyacetone |
| HMDB0001882 |
|
C00184 |
|
670 |
| Synonyms | Glycerone |
| No. of studies | 6 |
|
Relationship between Dihydroxyacetone and depression (count: 6) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M105 | Type1 | sCSDS group vs. control group | Plasma | C57BL/6JJmsSlc mouse | Down |
| Study M1072 | Type1 | CUMS group vs. control group | Plasma | Cynomolgus monkey | Down |
| Study M749 | Type1 | CUMS group vs. control group | Plasma | Cynomolgus monkey | Down |
| Study M882 | Type1 | CUMS group vs. control group | Jejunum | Sprague-Dawley rat | Down |
| Study M975 | Type1 | CUMS group vs. control group | Urine | Sprague-Dawley rat | Up |
| Study M975 | Type2 | CUMS + fluoxetine group vs. CUMS group | Urine | Sprague-Dawley rat | Down |
| Study M975 | Type2 | CUMS + high dose of Yang-Xin-Jie-Yu Decoction group vs. CUMS group | Urine | Sprague-Dawley rat | Down |
| Study M975 | Type2 | CUMS + middle dose of Yang-Xin-Jie-Yu Decoction group vs. CUMS group | Urine | Sprague-Dawley rat | Down |
| Study M975 | Type2 | CUMS + low dose of Yang-Xin-Jie-Yu Decoction group vs. CUMS group | Urine | Sprague-Dawley rat | Down |
| Study M981 | Type1 | Abeta oligomer group vs. control group | Serum | ICR mouse | Up |
| Study M981 | Type2 | Abeta oligomer + acousto-optic stimulation group vs. Abeta oligomer group | Serum | ICR mouse | Up |
| Study M981 | Type2 | Abeta oligomer + involuntary and voluntary running + acousto-optic stimulation group vs. Abeta oligomer group | Serum | ICR mouse | Up |
| Study M981 | Type2 | Abeta oligomer + involuntary and voluntary running group vs. Abeta oligomer group | Serum | ICR mouse | Down |